Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.

International journal of oncology

Volumn 15, Issue 3, 1999, Pages 541-546

  Lucci, A ^a   Han, T Y ^a   Liu, Y Y ^a   Giuliano, A E ^a   Cabot, M C ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; CERAMIDE; DOXORUBICIN; HORMONE ANTAGONIST; MIFEPRISTONE; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL SURVIVAL; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL SURVIVAL; CERAMIDES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY, COMBINATION; ESTROGEN ANTAGONISTS; FEMALE; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0033194699     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.3.541     Document Type: Article

References (0)